Meeting
2023 ASCO Annual Meeting
Association of Agent Orange and myeloproliferative neoplasms, thrombosis, and bleeding among veterans.
Authors
Andrew Chua Tiu
Georgetown Lombardi Comprehensive Cancer Center, Washington, DC
Andrew Chua Tiu , Zoe McKinnell , Shanshan Liu , Guoqing Diao , Puneet Gill , Nandan Srinivasa , Zoe Shancer , Martha Antonio , Ramesh Subrahmanyam , Maneesh Rajiv Jain
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Myeloproliferative Neoplasms (MPN) and Mast Cell Disorders
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 7011)
DOI
10.1200/JCO.2023.41.16_suppl.7011
Abstract #
7011
Poster Bd #
141
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Agent orange as a risk factor for high-grade prostate cancer detected on initial prostate biopsy.
First Author: N. J. Ansbaugh
Poster
2024 ASCO Annual Meeting
Association of elevated pulmonary artery systolic pressure with hematologic progression in myeloproliferative neoplasms.
First Author: Orly Leiva
Poster
2020 ASCO Virtual Scientific Program
Expression of CD47 and CALR in myeloproliferative neoplasms and myelodysplastic syndrome: Potential new therapeutical targets.
First Author: Ciro Roberto Rinaldi
Poster
2011 ASCO Annual Meeting
Evaluation of the JAK2 V617F mutational status in coronary patients.
First Author: K. Gasser